Biotech News

Edwards Lifesciences has announced that its TMVR product has been implanted in three patients.

Federal securities regulators have won a partial victory against two brothers accused of trading on inside information in 2009 about French pharmaceutical company Sanofi's plan to buy a Tennessee-based company.

Silicon Valley's first pure-tech IPO in 2014 brought in millions more than expected Thursday, as Coupons.com convinced investors it is worth more than $1 billion.

Officials haven't identified the boy, but say he passed away around 9 p.m. Wednesday at Allegheny General Hospital.

The settlement with Janssen Ortho LLC and Janssen Pharmaceuticals closes the latest in a string of lawsuits across the nation over the drug Risperdal, including a $2.2 billion settlement in November with the U.S. Department of Justice.

Drugmaker Endo Pharmaceuticals says it received U.S. approval for its long-acting testosterone injection Aveed, which joins a crowded field of hormone-boosting drugs for men.

Investors have seen the biotechnology momentum continue during Wednesday's trading session, with several biotechnology stocks producing significant gains.

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results.

What's the biggest theme in fund investing during 2014? If you guess bonds or emerging markets , you're missing something big.

The patent covers the use of sd-rxRNAs targeting CTGF, including RXI-109, for the treatment of fibrotic disorders.

The complete response letter referenced previously observed deficiencies at a Boehringer Ingelheim facility where empagliflozin will be manufactured.

It's crunch time for Obamacare: With less than four weeks left to sign up for coverage this year through the health law's insurance marketplaces, consumer groups, insurers, hospitals and state and federal officials are ratcheting up their enrollment campaigns to deliver more people - particularly young adults.

Flush with cash and high stock prices, American companies are buying up the competition at levels not seen since the dotcom bubble.

Julie Borlaug, granddaughter of Nobel Peace Prize laureate Dr. Norman Borlaug and associate director for the Norman Borlaug Institute for International Agriculture, delivers the keynote address advocating science and biotechnology as important tools in addressing global food security at the recent Ag Issues Forum in San Antonio.

1 Client Dashboard - along with five best-in-class ratings ... )--CST Brands, Inc. announced today that its Board of Directors has declared a quarterly cash dividend on the company's common stock in the amount of $0.0625 ... )--Cohu, Inc. today announced that Elmos Semiconductor AG , Germany, has chosen SATURN as its next generation handler ... (more)

Kim Bossley, right, gives a goodbye hug to research nurse Andrea Herman on Monday at University of Colorado Hospital.

A veterans group wants the Supreme Court to end a decades-long legal dispute over a memorial cross on a San Diego mountaintop that a lower court has found unconstitutional.

Synta Pharmaceuticals Corp., the maker of the experimental cancer drug ganetespib, said co- founder Safi Bahcall has resigned as chief executive officer and will be replaced by a committee led by Chairman Keith Gollust until a new top executive is named.

Craig Venter, the U.S. scientist who raced the U.S. government to map the human genome over a decade ago and created synthetic life in 2010, is now on a quest to treat age-related disease.

The Centers for Disease Control and Prevention reports that a little more than 1 percent of U.S. births occur at home, still just a fraction of all births.